CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Amgen Inc 's Quick Ratio

AMGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




AMGN Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Current Liabilities Change 38.6 % 8.81 % -9.21 % -7.3 % -0.93 %
Y / Y Cash & cash equivalent Change -29.24 % 31.88 % 19.48 % -40.73 % -47.51 %
Quick Ratio MRQ 0.55 0.82 0.91 1.24 1.09
Overall Ranking # # # # #
Seq. Current Liabilities Change 13.33 % 10.44 % 17.08 % -5.42 % -11.03 %
Seq. Cash & cash equivalent Change -23.51 % -0.76 % -13.86 % 8.22 % 42.55 %



Quick Ratio second quarter 2021 Comment
Due to increase in Current Liabilities in the second quarter 2021, Quick Ratio fell to 0.55 below Amgen Inc average.

Within Biotechnology & Drugs industry 197 other companies have achieved higher Quick Ratio than Amgen Inc in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are AMGN Segments?
See Quick Ratio AMGN on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 198
Healthcare Sector # 765
Overall Market # 2759


Quick Ratio Statistics
High Average Low
5.05 2.44 0.55
(Sep 30 2017)   (Jun 30 2021)




Financial Statements
Amgen Inc 's Current Liabilities $ 14,585 Millions Visit AMGN's Balance sheet
Amgen Inc 's Cash & cash equivalent $ 8,082 Millions Visit AMGN's Balance sheet
Source of AMGN's Sales Visit AMGN's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within Biotechnology & Drugs Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Bio techne Corp  1.52 $ 231.554  Millions$ 152.284  Millions
Vaxart Inc   1.51 $ 19.318  Millions$ 12.780  Millions
Cidara Therapeutics Inc   1.42 $ 48.284  Millions$ 33.887  Millions
Immunitybio Inc   1.40 $ 103.928  Millions$ 74.428  Millions
Biorestorative Therapies Inc   1.33 $ 1.759  Millions$ 1.326  Millions
Surgalign Holdings Inc   1.31 $ 69.257  Millions$ 52.799  Millions
Novavax inc   1.28 $ 2,121.278  Millions$ 1,651.516  Millions
Aziyo Biologics inc   1.20 $ 28.302  Millions$ 23.596  Millions
Emergent Biosolutions Inc   1.18 $ 447.500  Millions$ 377.800  Millions
Pharmacyte Biotech Inc   1.04 $ 0.959  Millions$ 0.925  Millions
Outlook Therapeutics Inc   1.00 $ 19.692  Millions$ 19.639  Millions
Svf Investment Corp 3  0.93 $ 2.707  Millions$ 2.902  Millions
Moderna Inc   0.90 $ 7,990.000  Millions$ 8,840.000  Millions
Champions Oncology Inc   0.75 $ 3.998  Millions$ 5.341  Millions
Fate Therapeutics inc   0.73 $ 76.654  Millions$ 105.600  Millions
Acorda Therapeutics inc   0.68 $ 45.714  Millions$ 67.656  Millions
Myriad Genetics Inc   0.61 $ 164.400  Millions$ 271.000  Millions
Health Discovery Corporation  0.60 $ 0.485  Millions$ 0.803  Millions
Amgen Inc   0.55 $ 8,082.000  Millions$ 14,585.000  Millions
Pactiv Evergreen Inc   0.46 $ 350.000  Millions$ 766.000  Millions
Agenus Inc  0.44 $ 73.543  Millions$ 168.754  Millions
Ortho Clinical Diagnostics Holdings Plc  0.42 $ 200.900  Millions$ 479.200  Millions
Biogen Inc   0.39 $ 1,308.800  Millions$ 3,347.200  Millions
Protalix Biotherapeutics inc   0.35 $ 33.882  Millions$ 96.247  Millions
Abbvie Inc   0.30 $ 8,600.000  Millions$ 28,684.000  Millions
Ainos Inc  0.26 $ 0.607  Millions$ 2.376  Millions
Cytodyn Inc   0.25 $ 33.943  Millions$ 133.298  Millions
Nascent Biotech Inc  0.24 $ 0.269  Millions$ 1.110  Millions
Gilead Sciences Inc   0.24 $ 1,632.000  Millions$ 6,924.000  Millions
Inhibitor Therapeutics Inc   0.22 $ 0.094  Millions$ 0.420  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CPSR's Profile

Stock Price

CPSR's Financials

Business Description

Fundamentals

Charts & Quotes

CPSR's News

Suppliers

CPSR's Competitors

Customers & Markets

Economic Indicators

CPSR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071